Hunan Jiudian Pharmaceutical Co., Ltd. (300705.SZ)
CNY 23.61
(-0.38%)
CNY 23.61
(-0.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 433.28 Million | 268.98 Million | 190.87 Million | 149.99 Million | 90.74 Million | 68.23 Million |
| Net Income | 368.26 Million | 269.7 Million | 204.24 Million | 82.25 Million | 55.06 Million | 71.98 Million |
| Depreciation & Amortization | 72.46 Million | 59.69 Million | 53.58 Million | 48.23 Million | 37.35 Million | 22.43 Million |
| Deferred income taxes | -24.16 Million | -8.47 Million | -11.34 Million | -2.98 Million | -8.87 Million | 2.01 Million |
| Stock-based compensation | 14.02 Million | 21.41 Million | - | - | - | - |
| Change in working capital | -10.82 Million | -126.06 Million | -103.14 Million | 5.25 Million | -11 Million | -28.69 Million |
| Other non-cash items | 210.26 Million | 65.65 Million | 36.19 Million | 14.23 Million | 9.32 Million | 2.5 Million |
| Investing Cash Flow | -426.67 Million | -431.35 Million | -229.55 Million | -78.3 Million | -178.92 Million | -256.26 Million |
| Investments in PPE | -426.81 Million | -413.38 Million | -125.92 Million | -78.35 Million | -181.98 Million | -257.26 Million |
| Acquisitions | 145.31 Thousand | 125.31 Thousand | -6.42 Million | 46.78 Thousand | 3.05 Million | 257.39 Million |
| Investment purchases | -180 Million | -360 Million | -380 Million | - | - | -150 Million |
| Sales/Maturities of investments | 180 Million | 341.9 Million | 282.53 Million | - | - | 150.85 Million |
| Other Investing Activities | 2.24 Million | 1.70 | 265.28 Thousand | 0.90 | 0.14 | -257.26 Million |
| Financing Cash Flow | 73.55 Million | 121.01 Million | 283.56 Million | -65.5 Million | 44.97 Million | 60.15 Million |
| Debt repayment | -212.89 Million | -124.38 Million | -17.74 Million | -71.63 Million | -54.53 Million | -44 Million |
| Dividends payments | -80.93 Million | -61.25 Million | -10.09 Million | -8.44 Million | -11.02 Million | -15.53 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 367.37 Million | 314.7 Million | 316.32 Million | 19.9 Million | 114.99 Million | 119.68 Million |
| Accounts receivables | -125.78 Million | -224.11 Million | -115.63 Million | -44.43 Million | 3.11 Million | -41.53 Million |
| Accounts payables | 112.06 Million | 138.61 Million | 100.75 Million | 76.66 Million | 23.82 Million | 24.65 Million |
| Inventory | -24.06 Million | -32.1 Million | -76.92 Million | -23.98 Million | -29.06 Million | -13.82 Million |
| Other working capital | 26.96 Million | -8.47 Million | -11.34 Million | -2.98 Million | -8.87 Million | -14.87 Million |
| Cash at beginning of period | 345.84 Million | 376.39 Million | 131.51 Million | 125.33 Million | 168.54 Million | 296.42 Million |
| Cash at end of period | 425.04 Million | 335.05 Million | 376.39 Million | 131.51 Million | 125.33 Million | 168.54 Million |
| Capital Expenditure | -426.81 Million | -413.38 Million | -125.92 Million | -78.35 Million | -181.98 Million | -257.26 Million |
| Effect of forex changes on cash | - | - | 0.15 | 0.60 | - | - |
| Net cash flow / Change in cash | 79.2 Million | -41.34 Million | 244.87 Million | 6.18 Million | -43.21 Million | -127.87 Million |
| Free Cash Flow | 6.46 Million | -144.39 Million | 64.94 Million | 71.64 Million | -91.24 Million | -189.02 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 165.6 Million | 158.46 Million | 125.66 Million | 368.26 Million | 58.27 Million | 112.36 Million |
| Depreciation & Amortization | - | 22.5 Million | 22.5 Million | 72.46 Million | 19.74 Million | -31.54 Million |
| Deferred income taxes | - | - | - | -24.16 Million | - | -9.23 Million |
| Stock-based compensation | - | 9.48 Million | - | 14.02 Million | 14.02 Million | -13.97 Million |
| Change in working capital | - | 54 Million | - | -10.82 Million | -122.88 Million | 54.76 Million |
| Other non-cash items | 19.29 Million | 44.92 Million | 112.5 Million | 210.26 Million | 6.44 Million | 77.41 Million |
| Investing Cash Flow | -194.39 Million | -128.19 Million | -126.37 Million | -426.67 Million | -144.22 Million | -78.67 Million |
| Investments in PPE | -123.98 Million | -56.4 Million | -86.41 Million | -426.81 Million | -144.26 Million | -78.73 Million |
| Acquisitions | -1.27 Million | 1.33 Million | 46 Thousand | 145.31 Thousand | 35.31 Thousand | 60 Thousand |
| Investment purchases | -248 Million | -173.12 Million | -40 Million | -180 Million | -90 Million | - |
| Sales/Maturities of investments | 178.87 Million | 100 Million | - | 180 Million | 90 Million | - |
| Other Investing Activities | -1.27 Million | -70.69 Million | -39.95 Million | 2.24 Million | 1.01 Million | 60 Thousand |
| Financing Cash Flow | -6.67 Million | -79.26 Million | -2.94 Million | 73.55 Million | -254.67 Million | 361.64 Million |
| Debt repayment | -5.65 Million | -13.46 Million | -2.01 Million | -212.89 Million | -260.61 Million | -21.18 Million |
| Dividends payments | -1.01 Million | -111.9 Million | -935.14 Thousand | -80.93 Million | -307.92 Thousand | -5.53 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -92.73 Million | -935.14 Thousand | 367.37 Million | 86.87 Million | 388.36 Million |
| Accounts receivables | - | 109.63 Million | - | -125.78 Million | -125.78 Million | 24.99 Million |
| Accounts payables | - | - | - | 112.06 Million | - | - |
| Inventory | - | -56.9 Million | - | -24.06 Million | -24.06 Million | 46.37 Million |
| Other working capital | - | 1.27 Million | - | 26.96 Million | 26.96 Million | -16.6 Million |
| Cash at beginning of period | 497.47 Million | 524.44 Million | 425.04 Million | 345.84 Million | 784.16 Million | 296.39 Million |
| Cash at end of period | 480.43 Million | 499.56 Million | 524.44 Million | 425.04 Million | 425.04 Million | 769.14 Million |
| Capital Expenditure | -123.98 Million | -56.4 Million | -86.41 Million | -426.81 Million | -144.26 Million | -78.73 Million |
| Effect of forex changes on cash | - | - | - | - | - | 0.65 |
| Net cash flow / Change in cash | -17.04 Million | -24.88 Million | 99.4 Million | 79.2 Million | -359.11 Million | 472.75 Million |
| Free Cash Flow | 60.91 Million | 124.46 Million | 151.75 Million | 6.46 Million | -99.28 Million | 111.04 Million |
IGC
STU
DHAMPURSUG
PEXZF
GSP
ORIENTELEC